Post

Zealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trial reut.rs/4hN1xq7

reut.rsZealand, Roche's obesity drug helps patients lose up to 9.2% weight in mid-stage trialZealand Pharma said on Wednesday its experimental drug helped people who are overweight or obese and have type 2 diabetes ‌lose up to 9.2% of their body weight in a mid-stage trial. The Danish company is developing it with Roche .

7/10/26, 7:50 pm4 reposts12 likes

Anton Van Gramberen

@antonvangramberen.bsky.social

Doesn’t sound impressive to me.